Although research on the role of CCL5 in the immune regulatory network in CRC patients has led to significant increases in understanding, determining the effects of changes to CCL5 actions in CRC patients, will provide further theoretical and practical directions for targeted immunotherapy strategies. This evidence concerns the gene CCL5 and colorectal carcinoma.